These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25213116)

  • 1. Beyond the treatment effect: Evaluating the effects of patient preferences in randomised trials.
    Walter SD; Turner R; Macaskill P; McCaffery KJ; Irwig L
    Stat Methods Med Res; 2017 Feb; 26(1):489-507. PubMed ID: 25213116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal allocation of participants for the estimation of selection, preference and treatment effects in the two-stage randomised trial design.
    Walter SD; Turner RM; Macaskill P; McCaffery KJ; Irwig L
    Stat Med; 2012 Jun; 31(13):1307-22. PubMed ID: 22362374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimising the two-stage randomised trial design when some participants are indifferent in their treatment preferences.
    Walter SD; Turner RM; Macaskill P
    Stat Med; 2019 Jun; 38(13):2317-2331. PubMed ID: 30793786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation in a single-blinded pediatric therapeutic strategy study for juvenile idiopathic arthritis: are parents and patient-participants in equipoise?
    Hissink Muller PCE; Yildiz B; Allaart CF; Brinkman DMC; van Rossum M; van Suijlekom-Smit LWA; van den Berg JM; Ten Cate R; de Vries MC
    BMC Med Ethics; 2018 Dec; 19(1):96. PubMed ID: 30572875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of treatment preference effects in clinical trials when some participants are indifferent to treatment choice.
    Walter SD; Turner RM; Macaskill P; McCaffery KJ; Irwig L
    BMC Med Res Methodol; 2017 Feb; 17(1):29. PubMed ID: 28219326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative efficiencies of alternative preference-based designs for randomised trials.
    Walter SD; Bian M
    Stat Methods Med Res; 2020 Dec; 29(12):3783-3803. PubMed ID: 32703124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taking a chance: How likely am I to receive my preferred treatment in a clinical trial?
    Walter SD; Blaha O; Esserman D
    Stat Methods Med Res; 2023 Mar; 32(3):572-592. PubMed ID: 36628522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample Size and Power When Designing a Randomized Trial for the Estimation of Treatment, Selection, and Preference Effects.
    Turner RM; Walter SD; Macaskill P; McCaffery KJ; Irwig L
    Med Decis Making; 2014 Aug; 34(6):711-9. PubMed ID: 24695962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insufficient evidence to determine the impact of patient preferences on clinical outcomes in acupuncture trials: a systematic review.
    Prady SL; Burch J; Crouch S; MacPherson H
    J Clin Epidemiol; 2013 Mar; 66(3):308-18. PubMed ID: 23347854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of patient preference on the design and interpretation of clinical trials.
    Feine JS; Awad MA; Lund JP
    Community Dent Oral Epidemiol; 1998 Feb; 26(1):70-4. PubMed ID: 9511845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised trials comparing different healthcare settings: an exploratory review of the impact of pre-trial preferences on participation, and discussion of other methodological challenges.
    Corbett MS; Watson J; Eastwood A
    BMC Health Serv Res; 2016 Oct; 16(1):589. PubMed ID: 27756285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of participant preferences in unblinded randomized controlled trials.
    Floyd AH; Moyer A
    J Empir Res Hum Res Ethics; 2010 Jun; 5(2):81-93. PubMed ID: 20569152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel preference-informed complementary trial (PICT) design for clinical trial research influenced by strong patient preferences.
    Ali S; Hopkin G; Poonai N; Richer L; Yaskina M; Heath A; Klassen TP; McCabe C; ;
    Trials; 2021 Mar; 22(1):206. PubMed ID: 33712062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised preference trial of medical versus surgical termination of pregnancy less than 14 weeks' gestation (TOPS).
    Robson SC; Kelly T; Howel D; Deverill M; Hewison J; Lie ML; Stamp E; Armstrong N; May CR
    Health Technol Assess; 2009 Nov; 13(53):1-124, iii-iv. PubMed ID: 19906334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conducting a two-stage preference trial: utility and challenges.
    Sidani S; Fox M; Epstein D
    Int J Nurs Stud; 2015 May; 52(5):1017-24. PubMed ID: 25736207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When referring physicians and researchers disagree on equipoise: the TOTAL trial experience.
    Rodrigues HC; Deprest J; v d Berg PP
    Prenat Diagn; 2011 Jun; 31(6):589-94. PubMed ID: 21484841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of participant and physician intervention preferences on randomized trials: a systematic review.
    King M; Nazareth I; Lampe F; Bower P; Chandler M; Morou M; Sibbald B; Lai R
    JAMA; 2005 Mar; 293(9):1089-99. PubMed ID: 15741531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What influences participants' treatment preference and can it influence outcome? Results from a primary care-based randomised trial for shoulder pain.
    Thomas E; Croft PR; Paterson SM; Dziedzic K; Hay EM
    Br J Gen Pract; 2004 Feb; 54(499):93-6. PubMed ID: 14965386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing trial efficiency by early reallocation of placebo nonresponders in sequential parallel comparison designs: application to antidepressant trials.
    Boessen R; Knol MJ; Groenwold RH; Grobbee DE; Roes KC
    Clin Trials; 2012 Oct; 9(5):578-87. PubMed ID: 23060319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methodological limitations prevent definitive conclusions on the effects of patients' preferences in randomized clinical trials evaluating musculoskeletal conditions.
    Franco MR; Ferreira ML; Ferreira PH; Maher CG; Pinto RZ; Cherkin DC
    J Clin Epidemiol; 2013 Jun; 66(6):586-98. PubMed ID: 23510556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.